Dr. Nerissa Kreher, MD, MBA
Dr. Kreher is a pediatric endocrinologist with more than 15 years of biotech industry experience in both Clinical Development and Medical Affairs. She has spent her career focused on drug development for patients with rare diseases in multiple therapeutic areas. Dr. Kreher was formerly the Chief Medical Officer of Entrada Therapeutics where she was responsible for Clinical Development, Medical Affairs, Regulatory, and Patient Advocacy. Her prior roles include Chief Medical Officer at Tiburio Therapeutics and Avrobio. Earlier in her career, she held roles of increasing responsibility at companies including Zafgen, Enobia (acquired by Alexion) and Genzyme. Dr. Kreher completed her pediatric endocrinology fellowship and pediatric residency at Riley Hospital for Children in Indianapolis. She received her M.D. from East Carolina University School of Medicine and her B.S. in Biology from The University of North Carolina at Chapel Hill.